Status:
RECRUITING
Identification of Responders to Platelet-Rich Plasma (PRP) Injections in Lateral Elbow Epicondylalgia
Lead Sponsor:
Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape
Conditions:
Lateral Epicondylitis of the Elbow
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this non-interventional study is to identify patients who respond to platelet-rich plasma (PRP) injections for chronic lateral epicondylalgia (tennis elbow) and to investigate factors asso...
Eligibility Criteria
Inclusion Criteria:
- Age ≥ 18 years
- Chronic lateral epicondylalgia (tennis elbow), diagnosed clinically or by imaging (ultrasound or MRI), evolving for more than 3 months
- PRP injection received within the last 48 hours
- Medically stable
- Able to provide informed consent/non-opposition
- Affiliation to a social security system
Exclusion Criteria:
- PRP injection received more than 48 hours before inclusion
- Participation in another clinical study with exclusion period
- Adults under legal protection
- Pregnant women
Key Trial Info
Start Date :
August 4 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT07496983
Start Date
August 4 2023
End Date
August 1 2026
Last Update
March 27 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles (CMRRF) de Kerpape
Ploemeur, France, 56270